|
American Academy of Pediatrics. Preterm and Low Birth Weight Infants. In: LK Pickering, editor. Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009. Arauz-Ruiz P, Norder H, Robertson BH and Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;83(8):2059-2073. Bartholomeusz A and Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol. 2004;14(1):3-16. Basuni AA, Butterworth L, Cooksley G, Locarnini S and Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine. 2004;22(21-22):2791-2799. Beasley RP and Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983;147(2):185-190. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY and Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099-1102. Bzowej NH. Hepatitis B Therapy in Pregnancy. Curr Hepat Rep. 2010;9(4):197-204. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ and Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336(8711):325-329. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R and Sanders R. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997;26(6):1658-1666. Centers for Disease Control [Taiwan]. Guidelines for treating persons receiving a complete course of hepatitis B vaccine but negative for antibodies to hepatitis B surface antigen. Retrieved April, 2013, from http://www.cdc.gov.tw/professional/page.aspx?treeid=5B0231BEB94EDFFC&nowtreeid=F93FD1BEB174A264. Centers for Disease Control [Taiwan]. Revision to the administration time of the first dose of hepatitis B vaccine. Retrieved November, 2011, from http://www.pediatr.org.tw/DB/News/file/1065-1.pdf. Centers for Disease Control [Taiwan]. Recommendations for immunoprophylaxis of low-birth-weight newborns with hepatitis B e antigen-positive mothers. Retrieved June, 2013, from http://www.pediatr.org.tw/db/paper/588/588_1.pdf. Chan CY, Lee SD, Tsai YT and Lo KJ. Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine. Vaccine. 1991;9(10):765-767. Chan HL, Wong VW, Wong GL, Tse CH, Chan HY and Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology. 2010;52(4):1232-1241. Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL and Marcellin P. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. J Hepatol. 2011;55(5):1121-1131. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY and Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855-1859. Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang DC, Ni YH, Chen CJ and Chen DS. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res. 2005;11(21):7953-7957. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS and Chen DS. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101(19):1348-1355. Chen DS and Sung JL. Hepatitis B virus infection on Taiwan. N Engl J Med. 1977;297(12):668-669. Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol. 2010;25(1):19-25. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY and Chen DS. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA. 1996;276(11):906-908. Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, Liu CC, Lee IH, Wu TC, Wu SF, Ni YH, Hsu HY, Chen DS and Chang MH. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology. 2004;39(1):58-63. Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, Huang FC, Wu SF, Chen SC, Wen WH, Chu CH, Ni YH, Hsu HY, Tsai PL, Chiang CL, Shyu MK, Lee PI, Chang FY and Chang MH. Effects of Maternal Screening and Universal Immunization to Prevent Mother-to-Infant Transmission of HBV. Gastroenterology. 2012;142(4):773-781 e772. Chevaliez S, Rodriguez C and Pawlotsky JM. New virologic tools for management of chronic hepatitis B and C. Gastroenterology. 2012;142(6):1303-1313 e1301. Chiou HL, Lee TS, Kuo J, Mau YC and Ho MS. Altered antigenicity of ''a'' determinant variants of hepatitis B virus. J Gen Virol. 1997;78 ( Pt 10):2639-2645. Chu CJ, Hussain M and Lok AS. Quantitative Serum HBV DNA Levels During Different Stages of Chronic Hepatitis B Infection. Hepatology. 2002a;36(6):1408-1415. Chu CJ, Hussain M and Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology. 2002b;122(7):1756-1762. Cooreman MP, van Roosmalen MH, te Morsche R, Sunnen CM, de Ven EM, Jansen JB, Tytgat GN, de Wit PL and Paulij WP. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology. 1999;30(5):1287-1292. Cooreman MP, Leroux-Roels G and Paulij WP. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci. 2001;8(3):237-247. De Silvestri A, Pasi A, Martinetti M, Belloni C, Tinelli C, Rondini G, Salvaneschi L and Cuccia M. Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun. 2001;2(7):367-372. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J and Schalm SW. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15(15):1624-1630. Desombere I, Willems A and Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens. 1998;51(6):593-604. Elwood M. Critical Appraisal of Epidemiological Studies and Clinical Trials, 3rd ed. New York: Oxford University Press; 2007. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009;49(5 Suppl):S185-195. Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G, Luo KX, Paik SW, Liaw YF, Button P and Popescu M. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology. 2008;47(2):428-434. Hadziyannis SJ and Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis. 2006;26(2):130-141. Han G-R, Cao M-K, Zhao W, Jiang H-X, Wang C-M, Bai S-F, Yue X, Wang G-J, Tang X and Fang Z-X. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Journal of Hepatology. 2011;55(6):1215-1221. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B and Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002;99(6):1049-1052. Hilleman MR, Buynak EB, Roehm RR, Tytell AA, Bertland AU and Lampson GP. Purified and inactivated human hepatitis B vaccine: progress report. Am J Med Sci. 1975;270(2):401-404. Hohler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, Vollmar J, Schneider PM and Fimmers R. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet. 2002;360(9338):991-995. Hsu HM, Lu CF, Lee SC, Lin SR and Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis. 1999;179(2):367-370. Hsu HM, Lee SC, Wang MC, Lin SF and Chen DS. Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan. Vaccine. 2001;19(20-22):2825-2829. Hsu HY, Chang MH, Chen DS, Lee CY and Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986;18(4):301-307. Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS, Lee CY and Hsieh KH. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine. 1993;11(14):1437-1440. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM and Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology. 1997;26(3):786-791. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF and Chen PJ. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis. 2010;201(8):1192-1200. Inui A, Komatsu H, Sogo T, Nagai T, Abe K and Fujisawa T. Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus. J Med Virol. 2007;79(6):670-675. Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ and Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology. 2010;51(5):1547-1554. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H and Cornberg M. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol. 2010;52(4):514-522. Kao JH, Chen PJ, Lai MY and Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000;118(3):554-559. Kao JH, Hsu HM, Shau WY, Chang MH and Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr. 2001;139(3):349-352. Kao JH, Chen PJ, Lai MY and Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol. 2002;40(1):22-25. Kao JH and Chen DS. Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan. Gastroenterology. 2003;125(6):1916-1917; author reply 1917-1918. Ko TM, Lin KH, Ho MM, Hwang MF, Hwang KC, Hsieh FJ, Yaung CL and Chen DS. Perinatal transmission of hepatitis B virus in the Taoyuan area. J Formos Med Assoc. 1986;85(4):341-351. Kobayashi M, Suzuki F, Arase Y, Akuta N, Suzuki Y, Hosaka T, Saitoh S, Tsubota A, Someya T, Ikeda K, Matsuda M, Sato J and Kumada H. Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001. J Gastroenterol. 2004;39(9):844-850. Krugman S and Giles JP. Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. N Engl J Med. 1973;288(15):755-760. Kwon JH, Jang JW, Lee S, Lee J, Chung KW, Lee YS and Choi JY. Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B. J Viral Hepat. 2012;19(2):e41-47. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107. Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP and Tong MJ. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology. 1986;6(3):369-373. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733-1745. Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM and Tang J. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet. 2009;126(5):685-696. Lin CL, Kao JH, Chen BF, Chen PJ, Lai MY and Chen DS. Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clin Infect Dis. 2005;41(11):1576-1581. Lin CL and Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci. 2008;15(2):137-145. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, Kawana T and Mizuno M. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr. 1987;111(6 Pt 1):877-881. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, Yang KH and Lee TY. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine. 1991;9(6):457-460. Lin HH, Kao JH, Chang TC, Hsu HY and Chen DS. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol. 2003;69(4):466-470. Liu CJ, Kao JH and Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int. 2005;25(6):1097-1107. Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE and McMahon BJ. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133(5):1452-1457. Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudeau A and et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis. 1985;152(4):817-822. Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346(22):1682-1683. Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ and Gewolb IH. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics. 1999;103(2):E14. Marion SA, Pastore MT, Pi DW and Mathias RG. Long-term Follow-up of Hepatitis B Vaccine in Infants of Carrier Mothers. American Journal of Epidemiology. 1994;140(8):734-746. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3(2):334-342. Milich DR and Leroux-Roels GG. Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev. 2003;2(5):248-257. Moriya T, Kuramoto IK, Yoshizawa H and Holland PV. Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit. J Clin Microbiol. 2002;40(3):877-880. Naito H, Hayashi S and Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39(1):362-364. National Center for Biotechnology Information. BLAST. Basic Local Alignment Search Tool. Retrieved October, 2010, from http://blast.ncbi.nlm.nih.gov/Blast.cgi. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M and Locarnini SA. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010;52(4):508-513. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS and Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135(9):796-800. Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS and Chen DS. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127(6):1733-1738. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY and Chen DS. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology. 2007;132(4):1287-1293. Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL and Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol. 2012;57(4):730-735. Norder H, Courouce AM and Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 1994;198(2):489-503. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y and Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575-2583. Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M and Gojobori T. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci U S A. 1989;86(18):7059-7062. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S and Mizokami M. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34(3):590-594. Pan CQ, Duan ZP, Bhamidimarri KR, Zou HB, Liang XF, Li J and Tong MJ. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012a;10(5):452-459. Pan CQ, Han GR, Jiang HX, Zhao W, Cao MK, Wang CM, Yue X and Wang GJ. Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2012b;10(5):520-526. Pan CQ, Mi LJ, Bunchorntavakul C, Karsdon J, Huang WM, Singhvi G, Ghany MG and Reddy KR. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci. 2012c;57(9):2423-2429. Perrillo R, Mimms L, Schechtman K, Robbins D and Campbell C. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing. Hepatology. 1993;18(6):1306-1312. Petersen J. HBV treatment and pregnancy. J Hepatol. 2011;55(6):1171-1173. Petrova M and Kamburov V. Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol. 2010;16(40):5042-5046. Rozanov M, Plikat U, Chappey C, Kochergin A and Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res. 2004;32(Web Server issue):W654-659. Sakamoto T, Tanaka Y, Simonetti J, Osiowy C, Borresen ML, Koch A, Kurbanov F, Sugiyama M, Minuk GY, McMahon BJ, Joh T and Mizokami M. Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. J Infect Dis. 2007;196(10):1487-1492. Seto WK, Wong DK, Fung J, Huang FY, Lai CL and Yuen MF. Reduction of hepatitis B surface antigen levels and HBsAg seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy. Hepatology. 2013. Shao ZJ, Xu DZ, Xu JQ, Li JH, Yan YP, Men K, Wang XP, Zhang ZY, Jiang QW and Zhang L. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study. J Gastroenterol Hepatol. 2007;22(2):165-170. Shi Z, Li X, Ma L and Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010;14(7):e622-634. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preiksaitis J and Lee B. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18(7):468-473. Stephenne J. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Vaccine. 1988;6(4):299-303. Stevens CE, Beasley RP, Tsui J and Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292(15):771-774. Stevens CE, Neurath RA, Beasley RP and Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3(3):237-241. Stirk HJ, Thornton JM and Howard CR. A topological model for hepatitis B surface antigen. Intervirology. 1992;33(3):148-158. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF and Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81(Pt 1):67-74. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai C-L, Gish RG, Ueda R, Miyakawa Y and Mizokami M. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 2003;124(4):925-932. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, Acharya SK, Gish RG, Kramvis A, Shimada T, Izumi N, Kaito M, Miyakawa Y and Mizokami M. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology. 2006;44(4):915-924. Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, Takahashi S, Shirai T, Hino K, Sakaida I and Mizokami M. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology. 2009;136(2):652-662 e653. Tabor E. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol. 2006;78(S1):S43-S47. Tang JR, Hsu HY, Lin HH, Ni YH and Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr. 1998;133(3):374-377. Thio CL, Thomas DL and Carrington M. Chronic viral hepatitis and the human genome. Hepatology. 2000;31(4):819-827. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV and Locarnini SA. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010;51(6):1933-1944. Tsai TY, Lo KJ and Lee SD. Immunoprophylaxis against hepatitis B virus infection: a controlled trial in infants born to HBeAg-negative HBsAg carrier mothers in Taiwan. Chin J Gasteroenterol. 1984;1(1):181-185. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL and Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol. 1991;34(2):96-99. Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS and Kao JH. Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters. Gastroenterology. 2011;141(2):517-525.e512. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS and Kao JH. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology. 2012a;55(1):68-76. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS and Kao JH. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012b;142(5):1140-1149 e1143. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y and Mayumi M. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods. 1999;80(1):97-112. Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J and Hou J. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003;71(3):360-366. Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T and Aoyagi Y. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations. J Gastroenterol Hepatol. 2005;20(3):441-449. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA and Levy MT. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190(9):489-492. World Health Organization. Hepatitis B vaccines: WHO position paper. Weekly Epidemiological Record 2009;84(40):405-420. Xu DZ, Yan YP, Choi BCK, Xu JQ, Men K, Zhang JX, Liu ZH and Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study. J Med Virol. 2002;67(1):20-26. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S and Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16(2):94-103. Xu YY, Yu JY, Zhong YW, Song HB, Liu HH, Jia LL, Li SL, Xu JQ and Li Q. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci. 2008;4(2):111-115. Yang J, Zeng XM, Men YL and Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review. Virol J. 2008;5:100. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS and Chen PJ. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol. 2004;41(4):659-666. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS and Chen CJ. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97(4):265-272. Zhang X, Lin SM, Ye F, Chen TY, Liu M, Chen YR, Zheng SQ, Zhao YR and Zhang SL. An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients. J Viral Hepat. 2011;18(7):e184-190. Zhang Z, Schwartz S, Wagner L and Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol. 2000;7(1-2):203-214. Zou H, Chen Y, Duan Z, Zhang H and Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18-25.
|